Contact this trialFirst, we need to learn more about you.
Targeted Contrast Agent
MT218 Injection for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Atlanta, Georgia
This trial aims to test the effectiveness of using a new injection called MT218 to help improve imaging of prostate cancer in patients before surgery.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service